HRV Norms by Age and Sex: What Is a Good Heart Rate Variability Score?

Every morning, millions of people check a number on a wrist or ring and feel either reassured or vaguely anxious. Heart rate variability — the millisecond-level fluctuations between consecutive heartbeats — has become one of the most closely watched metrics in consumer health technology. But unlike body temperature (where 37 °C is the widely accepted normal) or blood pressure (where 120/80 mmHg is a recognisable target), HRV has no single universal reference value. What counts as a healthy score at 25 looks different at 55, and the same absolute value can mean very different things depending on how it was measured, at what time of day, and how it compares to your own recent history.

This article unpacks what large-scale wearable datasets and published clinical research actually say about HRV norms across age and sex, explains why the metric you see on your device is only one piece of a more complex picture, and gives you a framework for interpreting your own score in a way that is more useful than simply comparing yourself to a population percentile.

Which HRV Metric Are We Talking About?

Before diving into norms, it is essential to clarify which metric is being discussed, because “HRV” encompasses several mathematically distinct measures that are not interchangeable. The three most clinically relevant are RMSSD, SDNN, and high-frequency (HF) power.

RMSSD — the root mean square of successive differences between adjacent RR intervals — is the metric almost all consumer wearables (WHOOP, Garmin, Oura, Polar, Apple Watch) report, because it reflects parasympathetic (vagal) nervous system activity and can be reliably calculated from short recordings of just two to five minutes. Normal population RMSSD values in healthy adults range from roughly 20 ms to over 100 ms, with wide individual variation.

SDNN — the standard deviation of all normal RR intervals across a full 24-hour recording — captures both sympathetic and parasympathetic contributions to heart rate variability over an entire day. A healthy SDNN in a 24-hour Holter recording typically falls between 100 and 170 ms. SDNN is the gold-standard metric in clinical cardiology and is a strong predictor of arrhythmia risk and all-cause mortality, but it requires a full-day recording — impractical for daily wearable use. Values below 50 ms on a clinical 24-hour recording are associated with significantly elevated cardiovascular risk.

High-frequency (HF) power (0.15–0.40 Hz in the frequency domain) specifically reflects respiratory-driven vagal tone — essentially what happens to heart rate during each breathing cycle. HF power is the cleanest isolator of parasympathetic activity, which is why it appears in clinical research on cardiac autonomic neuropathy, sleep disorders, and biofeedback protocols. When wearable companies or apps reference “HRV” without qualification, they almost always mean RMSSD. The age norms discussed below refer to RMSSD unless stated otherwise.

What Large Wearable Datasets Reveal About Age-Stratified Norms

The most comprehensive population-level HRV data now come not from clinical studies — which typically involve hundreds or a few thousand participants — but from wearable platforms with millions of users. Polar, Garmin, WHOOP, and Oura have each published analyses of their user bases. The 2021 WHOOP analysis of over 35,000 users and the Polar dataset of more than 100,000 users provide the clearest age-stratified RMSSD distributions available.

These datasets converge on a consistent pattern. In the 20–29 age band, population median RMSSD sits around 65–75 ms, with the 25th percentile at approximately 45 ms and the 75th percentile reaching 90–100 ms. The 30–39 band shows a median of 55–65 ms. The 40–49 band drops to 40–55 ms median. By the 50–59 decade, median RMSSD is in the 30–45 ms range, and in adults over 60, median values cluster between 25 and 40 ms.

Critically, the variance within each age band is enormous. A fit 58-year-old marathon runner may post RMSSD values of 80 ms or more, while a sedentary 28-year-old under chronic stress might average 30 ms. This overlap across decades means that using age-band averages as targets is misleading — they describe the population mean, not what is optimal for any given individual. The slope of decline matters more than any single value.

How Does HRV Differ Between Women and Men?

Sex differences in HRV are real but often misunderstood. At first glance, the data appear to show that men have higher HRV than women across most age groups when absolute RMSSD is compared. A 2018 meta-analysis by Nunan et al. covering over 21,000 subjects found that men had modestly but consistently higher RMSSD values than age-matched women in resting short-term recordings. However, this difference is partly an artefact of heart rate differences: women tend to have slightly higher resting heart rates than men, and higher heart rate mechanically constrains the inter-beat interval range, compressing absolute HRV values even when vagal tone is equivalent.

When frequency-domain analysis is used and HF power is normalised for total spectral power — effectively correcting for heart rate — sex differences in parasympathetic tone narrow considerably and in some studies disappear or even reverse in favour of women. This suggests that the female cardiovascular system may have equivalent or superior vagal modulation, expressed differently due to the faster baseline rhythm.

The most pronounced sex difference emerges around menopause. Before menopause, oestrogen has well-documented cardioprotective effects, including enhancement of vagal tone and baroreflex sensitivity. After menopause, the withdrawal of oestrogen accelerates the age-related decline in HRV. Several large studies, including work from the Women’s Health Initiative dataset, show that the post-menopausal HRV trajectory is steeper than the age-matched male decline. Hormone replacement therapy appears to partially attenuate this effect: a 2019 randomised controlled trial found that women on oral oestradiol had significantly higher RMSSD values than placebo-matched controls over a two-year follow-up. This is an area of active clinical investigation.

Why Elite Athletes Have Dramatically Higher HRV

One of the most striking observations in HRV research is the magnitude of the athletic advantage. Elite endurance athletes — professional road cyclists, marathon runners, rowers, and cross-country skiers — routinely display resting RMSSD values of 90–140 ms, values that in a sedentary population would be at the 99th percentile or higher. These numbers are not flukes of measurement; they reflect genuine and durable adaptations of the autonomic nervous system to sustained aerobic training.

The mechanisms driving this elevation are well characterised. Chronic endurance training increases cardiac vagal efferent activity, measurably thickens the parasympathetic innervation density of the sinus node, and produces left ventricular hypertrophy that raises stroke volume — meaning a lower resting heart rate is sufficient to meet metabolic demand. The lower the resting heart rate, the wider the inter-beat interval, and — critically — the larger the window within which autonomic fluctuations can express themselves. This is why athletic bradycardia and high HRV are mechanistically linked rather than coincidental.

A 2016 review in the International Journal of Sports Physiology and Performance compiled RMSSD data from over 50 studies of trained athletes and found that even moderately trained recreational athletes — those running 30–50 km per week — showed RMSSD values 20–35% higher than sedentary age-matched controls. The dose-response relationship is roughly log-linear: each doubling of weekly aerobic training volume is associated with an approximately 10–15% increase in resting RMSSD, with diminishing returns at very high training volumes where overtraining begins to suppress HRV.

Factors That Temporarily Suppress HRV

Understanding what temporarily lowers HRV is as important as knowing your baseline, because transient suppression is a normal biological response to physiological stressors — not evidence of permanent cardiovascular dysfunction. The most reliably documented acute HRV suppressors include alcohol consumption, poor sleep, psychological stress, viral illness, and excessive training load.

Alcohol has one of the largest acute effects on HRV of any common lifestyle factor. A single evening of moderate drinking (2–3 standard drinks) suppresses RMSSD measured the following morning by an average of 22% in studies from the WHOOP dataset and independent clinical trials. This suppression is dose-dependent and persists for 24–48 hours after the last drink. The mechanism involves both direct vagolytic effects of ethanol on cardiac conduction and the sympathetic activation that accompanies hepatic alcohol metabolism.

Sleep quality has a particularly tight coupling with morning HRV. Studies using polysomnography show that reductions in slow-wave sleep (deep sleep) correlate strongly with suppressed next-morning RMSSD, even when total sleep duration is unchanged. A single night of four-hour sleep restriction reduces the following morning’s RMSSD by approximately 8–12% in otherwise healthy subjects. Chronic sleep restriction produces cumulative suppression that can mask underlying cardiovascular fitness when monitoring HRV trends.

Acute psychological stress — including occupational stress, competitive anxiety, and interpersonal conflict — suppresses HRV through hypothalamic-pituitary-adrenal axis activation and the resulting elevation in circulating cortisol and catecholamines. This is why HRV biofeedback and mindfulness-based stress reduction programmes targeted at HRV elevation work partly by lowering allostatic load rather than directly training the cardiovascular system.

Viral illness, even subclinical infection, consistently reduces HRV before other symptoms appear. Several studies of elite athletes during COVID-19 found that HRV dropped measurably two to four days before athletes reported feeling unwell — a finding that has driven interest in HRV as an early warning system for infectious illness. The inflammatory cytokines released during immune activation directly suppress parasympathetic activity at the level of the cardiac ganglia.

How to Interpret Your Own HRV Score Correctly

The most useful frame for interpreting your HRV is not a population comparison but a personalised baseline with a trend overlay. Most wearable platforms now calculate a rolling baseline from your previous 30 to 90 days of measurements, then express your current reading as deviation from that baseline — either as a percentage, a z-score, or a colour-coded status. This approach is scientifically more meaningful than population percentiles, because the primary signal you are trying to extract is not “am I as healthy as the average 42-year-old?” but rather “is my body more or less recovered today than usual?”

A consistent pattern of below-baseline readings over five to ten consecutive days — especially in the absence of obvious lifestyle stressors — warrants clinical attention, regardless of whether the absolute value falls within a population’s “normal” range. Conversely, a gradual upward trend in your personal baseline over weeks and months, driven by aerobic training, improved sleep, or stress management, is evidence of genuine cardiovascular adaptation even if your absolute score remains modest by comparison to a younger or more athletic cohort.

Measurement consistency is non-negotiable for meaningful trend analysis. RMSSD is sensitive to body position, time of measurement, recent caffeine intake, and respiratory rate. The most reproducible readings come from a standardised morning measurement: immediately upon waking, before caffeine, after two to three minutes of supine rest, and with relaxed nasal breathing at a comfortable pace. Deviating from this protocol on any given day introduces variance that can swamp the biological signal you are trying to track.